- Trials with a EudraCT protocol (43)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
43 result(s) found for: Beta D Glucose.
Displaying page 1 of 3.
EudraCT Number: 2010-024487-18 | Sponsor Protocol Number: DvitamininDM2_v1 | Start Date*: 2011-06-20 | ||||||||||||||||||||||||||
Sponsor Name:Dept. of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital | ||||||||||||||||||||||||||||
Full Title: Effects of vitamin D on beta cell function and insulin sensitivity in pre-diabetes and diabetes mellitus type 2 - EVIDENS | ||||||||||||||||||||||||||||
Medical condition: Impaired glucose tolerance, impaired fasting glucose and type 2 diabetes mellitus. Vitamin D deficiency. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003755-64 | Sponsor Protocol Number: DiAPREV/2014 | Start Date*: 2014-11-13 |
Sponsor Name:Helena Elding Larsson | ||
Full Title: A double-blind, randomized investigator-initiated study to determine the safety and the effect of Diamyd® in combination with Vitamin D on the progression to type 1 diabetes in children with multip... | ||
Medical condition: Children with HLA risk and persistent islet autoantibody positivity which is associated with a defined risk for type 1 diabetes | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022075-66 | Sponsor Protocol Number: 10/CMC/4767E | Start Date*: 2010-12-16 |
Sponsor Name:Cardif and Vale University Local Health Board | ||
Full Title: A Single Centre Physiological Study of Glucose Metabolism Before and After Tacrolimus Withdrawal For Deteriorating Kidney Function In Renal Transplant Recipients | ||
Medical condition: Alterations in glucose metabolism secondary to tacrolimus (Prograf), a calcineurin inhibitor, after kidney transplantation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-015776-95 | Sponsor Protocol Number: ENM-DA012 | Start Date*: 2010-03-24 |
Sponsor Name:Universitätsklinik für Innere Medizin, Klinische Abteilung für Endokrinologie und Nuklearmedizin | ||
Full Title: Effects of vitamin D supplementation in coronary artery disease patients with postchallenge hyperglycemia and vitamin D deficiency on endothelial function and insulin sensivitivity | ||
Medical condition: subjects with coronary artery disease, postchallenge hyperglycemia and low levels of 24-OH-vitamin D | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000994-30 | Sponsor Protocol Number: VD1.3 | Start Date*: 2013-02-19 |
Sponsor Name:Medizinische Universität Graz | ||
Full Title: A randomized, double‐blind, placebo controlled trial to evaluate the effects of vitamin D supplementation on metabolic and fertility parameters in PCOS women | ||
Medical condition: Polycystic Ovary Syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000121-31 | Sponsor Protocol Number: PSYK-TREAT-HEALTHY | Start Date*: 2013-03-20 | |||||||||||
Sponsor Name:Prof., dr. med. Anders Fink-Jensen | |||||||||||||
Full Title: Does a GLP-1 receptor agonist change glucose tolerance in antipsychotic-treated patients? | |||||||||||||
Medical condition: Dysglycaemia, schizophrenia, paranoid psycosis, schizotypal disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003207-35 | Sponsor Protocol Number: APCP-115,amendment | Start Date*: 2013-08-13 | ||||||||||||||||
Sponsor Name:Karolinska University Hospital Solna | ||||||||||||||||||
Full Title: Effects of ARA 290, a non-hematopoietic erythropoietin analog, on glucose tolerance, insulin secretion, insulin sensitivity and long-term glucose control in individuals with prediabetes and/or dru... | ||||||||||||||||||
Medical condition: For the complementary visits; up to 12 Subjects with Prediabetes (impaired fasting glucose, impaired glucose tolerance) or diet-treated type 2 diabetes, will be chosen from the currently approved c... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001552-30 | Sponsor Protocol Number: PRED-D-TRIAL2015 | Start Date*: 2015-10-13 | |||||||||||
Sponsor Name:Steno Diabetes Center A/S | |||||||||||||
Full Title: Effect of dapagliflozin, metformin and physical activity on glucose variability, body composition and cardiovascular risk in pre-diabetes (The PRE-D Trial) - A randomised, parallel, open-label, int... | |||||||||||||
Medical condition: Pre-diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000225-30 | Sponsor Protocol Number: DMA-Clin-199-2013-001 | Start Date*: 2013-04-12 | |||||||||||
Sponsor Name:DiaMedica USA Inc. | |||||||||||||
Full Title: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, SINGLE DOSE AND MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND PROOF OF CONCEPT OF DM-199 IN HEALTHY SUBJECTS... | |||||||||||||
Medical condition: Diabetes Mellitus type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005405-78 | Sponsor Protocol Number: 2011430 | Start Date*: 2012-02-01 | ||||||||||||||||
Sponsor Name:Steen Bendix Haugaard | ||||||||||||||||||
Full Title: Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes | ||||||||||||||||||
Medical condition: Patients suffering of both Type 2 diabetes mellitus and coronary artery disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005825-12 | Sponsor Protocol Number: PB-06-002 | Start Date*: 2009-06-04 | |||||||||||
Sponsor Name:Protalix Biotherapeutics | |||||||||||||
Full Title: Ensayo clinico de fase 3, multicéntrico, en abierto y con cambio de tratamiento para evaluar la seguridad y eficacia de Glucocerebrosidasa Humana Recombinante expresada en células vegetales (prGCD)... | |||||||||||||
Medical condition: Enfermedad de Gaucher Gaucher Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GB (Completed) IT (Completed) DE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001778-32 | Sponsor Protocol Number: U1111-1149-7801 | Start Date*: 2014-08-12 | |||||||||||||||||||||
Sponsor Name:Bo Feldt-Rasmussen | |||||||||||||||||||||||
Full Title: Glycaemic and cardiovascular efficacy of liraglutide in prediabetic patients with end-stage renal disease | |||||||||||||||||||||||
Medical condition: Prediabetes and dialysis dependent end-stage renal disease | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003575-11 | Sponsor Protocol Number: VitaminD&TT | Start Date*: 2013-03-05 | |||||||||||
Sponsor Name:Medizinische Universität Graz, Innere Medizin | |||||||||||||
Full Title: A randomized, double-blind, placebo controlled trial to evaluate the effects of vitamin D supplementation on androgen levels in hypogonadal men | |||||||||||||
Medical condition: Male hypogonadism (total testosterone <3ng/ml) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005229-95 | Sponsor Protocol Number: PBKR03-001 | Start Date*: 2021-08-23 | |||||||||||
Sponsor Name:Passage Bio, Inc. | |||||||||||||
Full Title: A Phase 1/2 Open-Label, Multicenter, Dose Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of PBKR03 Administered to Pediatric Subjects with Early Infantile Krabbe Dis... | |||||||||||||
Medical condition: Krabbe disease (globoid cell leukodystrophy) is an autosomal recessive lysosomal storage disease (LSD) caused by mutations in the gene encoding the hydrolytic enzyme galactosylceramidase (galactoce... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002271-41 | Sponsor Protocol Number: ATS K020 (D-PIO 112) | Start Date*: 2006-10-25 | |||||||||||
Sponsor Name:Takeda Pharma GmbH | |||||||||||||
Full Title: Effects of Pioglitazone in Combination with Glimepiride in Comparison to Glimepiride Monotherapy on Metabolic Control in Patients with Type 2 Diabetes mellitus | |||||||||||||
Medical condition: Patients with Type 2 Diabetes mellitus and HbA1c > 6,5%, but < 8,5% and/ or fasting plasma glucose > 7 mmol/l will be eligible for the study | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011003-23 | Sponsor Protocol Number: GFT505-209-4 | Start Date*: 2009-05-28 | ||||||||||||||||
Sponsor Name:GENFIT | ||||||||||||||||||
Full Title: A Pilot study to evaluate the Efficacy and Safety of GFT505 (80mg) orally administered once daily for 35 days in patients presenting with impaired glucose tolerance and abdominal obesity. A double ... | ||||||||||||||||||
Medical condition: patients presenting with impaired glucose tolerance and abdominal obesity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-002758-31 | Sponsor Protocol Number: ECD01 | Start Date*: 2006-12-22 | |||||||||||
Sponsor Name:EPOPLUS GmbH & Co.KG | |||||||||||||
Full Title: A randomized, double-blind, multi-centre, placebo-controlled, parallel-group study to examine the efficacy and safety of low dose Epoetin beta on wound healing in diabetes patients with foot ulcer | |||||||||||||
Medical condition: wound healing in diabetes patients with foot ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BG (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002101-35 | Sponsor Protocol Number: HyperCarD2 | Start Date*: 2017-08-24 |
Sponsor Name:Sten Madsbad | ||
Full Title: THE ROLE OF HYPERGLYCEMIA, HYPERINSULINEMIA AND ELEVATED FREE FATTY ACIDS FOR CARDIAC FUNCTION IN PATIENTS WITH TYPE 2 DIABETES – THE HYPERCARD2 STUDY | ||
Medical condition: typé 2 diabetes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002772-12 | Sponsor Protocol Number: 2020PI088 | Start Date*: 2020-07-17 | |||||||||||
Sponsor Name:CHRU NANCY | |||||||||||||
Full Title: Efficacy of infusions of mesenchymal stem cells from Wharton jelly in the moderate to severe SARS-Cov-2 related acute respiratory distress syndrome (COVID-19): A Phase IIa double-blind randomized ... | |||||||||||||
Medical condition: Moderate to severe SARS-Cov-2 related acute respiratory distress syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002312-43 | Sponsor Protocol Number: 01052020 | Start Date*: 2020-05-28 |
Sponsor Name:Miguel Cervero Jiménez, servicio de Medicina Interna, Hospital Universitario Severo Ochoa | ||
Full Title: Clinical trial, PHASE III, randomized, open-label, to evaluate the efficacy of administering high-dose cholecalciferol orally alongside standard therapy in patients with COVID-19 pneumonia (COVID-1... | ||
Medical condition: COVID-19 PNEUMONIA | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.